Download PDF
CC BY-NC-ND 4.0 · Arch Plast Surg 2022; 49(03): 462-470
DOI: 10.1055/s-0042-1748665
Research/Experimental
Original Article

Coactivity of Mast Cells and Stem Cells on Angiogenesis and Antioxidants' Potentials at Inflammation, Proliferation, and Tissue Remodeling Phases of Wound

Mahshad Mousavi 
1   Student Research Committee, Lorestan University of Medical Sciences, Khorramabad, Iran
,
Ahmad Khanifar 
1   Student Research Committee, Lorestan University of Medical Sciences, Khorramabad, Iran
,
Nazanin Mousavi 
1   Student Research Committee, Lorestan University of Medical Sciences, Khorramabad, Iran
,
Khatereh Anbari 
2   Community Medicine Department, Lorestan University of Medical Sciences, Khorramabad, Iran
,
Farzaneh Chehelcheraghi 
3   Anatomical Sciences Department, Lorestan University of Medical Sciences, Khorramabad, Iran
› Author Affiliations Funding Lorestan University of Medical Sciences (LUMS) has supported this study with approval code 446, which was also a student thesis (code 493). The results of this study are presented honestly, without any fabrication or manipulation of the data.
› Further Information
   Permissions and Reprints

Abstract

Background Reactive oxygen species cause serious damage to the physiological function of tissues. Determination of total antioxidant capacity of skin tissue is one of the determinants of damaged tissue function. Mast cells (MCs) are one of the groups of cells that are invited to the site of injury. The healing process begins with the rapid release of various types of MCs' intermediate factors at the site of injury. Bone marrow mesenchymal stem cell (BMMSC) production and secretion have been shown to regenerate the skin. The aim of this research was to evaluate the wound-healing and antioxidant effects of BMMSCs per MCs.

Methods Fifty-four albino Wistar male rats were divided into three groups: (1) nonsurgery, (2) surgery, and (3) surgery + BMMSCs. Groups 2 and 3 were operated with a 3 × 8 cm flap and in group 3, cell injections (7 × 109 cell injection at the time of surgery) were performed. After days 4, 7, and 15, percentage of the surviving tissue, histological characteristics, superoxide dismutase (SOD) activity, and amount of malondialdehyde (MDA) were measured in the groups. For results, Graph Pad Prism 8 software was used, and data were analyzed and compared by analysis of variance and Tukey test.

Results BMMSCs' application decreased the amount of MDA, increased SOD activity and survival rate of the flaps, and improved the histological characteristics.

Conclusion This study revealed the protective effects BMMSCs alongside MCs against oxidative stress on the survival of the flaps. However, for clinical use, more research is needed to determine its benefits.

Keywords

reactive oxygen species - antioxidant - superoxide dismutase - wound healing

Author Contributions

M.M. and K.A. performed research. M.N. performed research and wrote the paper.A.K. analyzed and interpreted the data. C.F. was involved in conception and design, critical revision, and final approval of the version to be published.


Animal Experiment Care Approval

This study was performed according to the “guidelines for taking care of and using laboratory animals” prepared by faculty of medicine at Lorestan University of Medical Sciences (LUMS.REC.1396.254).


Prior Presentation

Our article is taken from a student thesis (code 493) submitted for the award of doctoral degree: Doctoral dissertation by Mr. Ahmad Khanifar.




Publication History

Article published online:
27 May 2022

© 2022. The Korean Society of Plastic and Reconstructive Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Murugan R, Padma S, Senthilkumaran M. Risk factors deciding the prevention and healing of diabetic foot ulcer: a prospective study in Chennai Medical College Hospital and Research Center Irungalur, Trichy, Tamil Nadu, India; a rural based tertiary medical care centre. Int Surg J 2018; 5 (05) 1770-1775
    CrossrefGoogle Scholar
  • 2 Wang JC, Xia L, Song XB, Wang CE, Wei FC. Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells improves survival of ultra-long random skin flap. Chin Med J (Engl) 2011; 124 (16) 2507-2511
    Google Scholar
  • 3 Cheng H-F, Feng Y, Jiang D-M, Tao K-Y, Kong M-J. Protective function of tocilizumab in human cardiac myocytes ischemia reperfusion injury. Asian Pac J Trop Med 2015; 8 (01) 48-52
    CrossrefPubMedGoogle Scholar
  • 4 Wang WZ, Baynosa RC, Zamboni WA. Update on ischemia-reperfusion injury for the plastic surgeon: 2011. Plast Reconstr Surg 2011; 128 (06) 685e-692e
    CrossrefPubMedGoogle Scholar
  • 5 Hentz V, Mathes S. Plastic Surgery. Philadelphia, PA: Lippincott Williams & Wilkins; 2006
    Google Scholar
  • 6 Kumar V, Abbas A, Fausto N, Mitchell R. Chapter 1. Cell injury, cell death, and adaptations. In: Kumar V, Abbas AK, Fausto N, Mitchell R. eds. Robbins Basic Pathology. 8th edition.. Philadelphia: Elsevier–Saunders; 2007: 13-17
    Google Scholar
  • 7 Ozen S, Akisu M, Baka M. et al. Insulin-like growth factor attenuates apoptosis and mucosal damage in hypoxia/reoxygenation-induced intestinal injury. Biol Neonate 2005; 87 (02) 91-96
    CrossrefPubMedGoogle Scholar
  • 8 Panich U, Ananta W, Onkoksoong T, Jaemsak K. Effects of cellular uptake of flavonoids against peroxynitrite-mediated cell cytotoxicity. Siriraj Med J 2007; 59 (05) 237-241
    Google Scholar
  • 9 Pazoki-Toroudi H, Nassiri-Kashani M, Tabatabaie H. et al. Combination of azelaic acid 5% and erythromycin 2% in the treatment of acne vulgaris. J Dermatolog Treat 2010; 21 (03) 212-216
    CrossrefPubMedGoogle Scholar
  • 10 Habibey R, Ajami M, Ebrahimi SA, Hesami A, Babakoohi S, Pazoki-Toroudi H. Nitric oxide and renal protection in morphine-dependent rats. Free Radic Biol Med 2010; 49 (06) 1109-1118
    CrossrefPubMedGoogle Scholar
  • 11 Todorova D, Simoncini S, Lacroix R, Sabatier F, Dignat-George F. Extracellular vesicles in angiogenesis. Circ Res 2017; 120 (10) 1658-1673
    CrossrefPubMedGoogle Scholar
  • 12 James TJ, Hughes MA, Cherry GW, Taylor RP. Evidence of oxidative stress in chronic venous ulcers. Wound Repair Regen 2003; 11 (03) 172-176
    CrossrefPubMedGoogle Scholar
  • 13 Banimohammad M, Ravaei H, Khalafi P, Javdan G, Ayatollahi SA, Davoodi SH. Change in total anti-oxidant capacity (TAC) of tissue, a new method for improving dermal wound healing. Majallah-i Ilmi-i Danishgah-i Ulum-i Pizishki-i Kurdistan 2019; 24 (03) 96-109
    Google Scholar
  • 14 Yu W-Y, Sun W, Yu D-J, Zhao T-L, Wu L-J, Zhuang H-R. Adipose-derived stem cells improve neovascularization in ischemic flaps in diabetic mellitus through HIF-1α/VEGF pathway. Eur Rev Med Pharmacol Sci 2018; 22 (01) 10-16
    PubMedGoogle Scholar
  • 15 Uysal CA, Ogawa R, Lu F, Hyakusoku H, Mizuno H. Effect of mesenchymal stem cells on skin graft to flap prefabrication: an experimental study. Ann Plast Surg 2010; 65 (02) 237-244
    CrossrefPubMedGoogle Scholar
  • 16 Younan GJ, Heit YI, Dastouri P. et al. Mast cells are required in the proliferation and remodeling phases of microdeformational wound therapy. Plast Reconstr Surg 2011; 128 (06) 649e-658e
    CrossrefPubMedGoogle Scholar
  • 17 Weller K, Foitzik K, Paus R, Syska W, Maurer M. Mast cells are required for normal healing of skin wounds in mice. FASEB J 2006; 20 (13) 2366-2368
    CrossrefPubMedGoogle Scholar
  • 18 Kim D-K, Beaven MA, Kulinski JM. et al. Regulation of reactive oxygen species and the antioxidant protein DJ-1 in mastocytosis. PLoS One 2016; 11 (09) e0162831
    CrossrefPubMedGoogle Scholar
  • 19 Zhang P, Feng J, Liao Y. et al. Ischemic flap survival improvement by composition-selective fat grafting with novel adipose tissue derived product - stromal vascular fraction gel. Biochem Biophys Res Commun 2018; 495 (03) 2249-2256
    CrossrefPubMedGoogle Scholar
  • 20 Yang M, Sheng L, Li H, Weng R, Li QF. Improvement of the skin flap survival with the bone marrow-derived mononuclear cells transplantation in a rat model. Microsurgery 2010; 30 (04) 275-281
    CrossrefPubMedGoogle Scholar
  • 21 Kakkar P, Das B, Viswanathan PN. A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys 1984; 21 (02) 130-132
    PubMedGoogle Scholar
  • 22 Davoodi F, Taheri S, Raisi A. et al. Investigating the sperm parameters, oxidative stress and histopathological effects of salvia miltiorrhiza hydroalcoholic extract in the prevention of testicular ischemia reperfusion damage in rats. Theriogenology 2020; 144: 98-106
    CrossrefPubMedGoogle Scholar
  • 23 Rahman ZA, Soory M. Antioxidant effects of glutathione and IGF in a hyperglycaemic cell culture model of fibroblasts: some actions of advanced glycaemic end products (AGE) and nicotine. Endocr Metab Immune Disord Drug Targets 2006; 6 (03) 279-286
    CrossrefPubMedGoogle Scholar
  • 24 Tsao Y-P, Ho T-C, Chen S-L, Cheng H-C. Pigment epithelium-derived factor inhibits oxidative stress-induced cell death by activation of extracellular signal-regulated kinases in cultured retinal pigment epithelial cells. Life Sci 2006; 79 (06) 545-550
    CrossrefPubMedGoogle Scholar
  • 25 Kim W-S, Park B-S, Kim H-K. et al. Evidence supporting antioxidant action of adipose-derived stem cells: protection of human dermal fibroblasts from oxidative stress. J Dermatol Sci 2008; 49 (02) 133-142
    CrossrefPubMedGoogle Scholar
  • 26 Trautmann A, Toksoy A, Engelhardt E, Bröcker EB, Gillitzer R. Mast cell involvement in normal human skin wound healing: expression of monocyte chemoattractant protein-1 is correlated with recruitment of mast cells which synthesize interleukin-4 in vivo. J Pathol 2000; 190 (01) 100-106
    CrossrefPubMedGoogle Scholar
  • 27 Wulff BC, Wilgus TA. Mast cell activity in the healing wound: more than meets the eye?. Exp Dermatol 2013; 22 (08) 507-510
    CrossrefPubMedGoogle Scholar
  • 28 Levi-Schaffer F, Kupietzky A. Mast cells enhance migration and proliferation of fibroblasts into an in vitro wound. Exp Cell Res 1990; 188 (01) 42-49
    CrossrefPubMedGoogle Scholar
  • 29 Noli C, Miolo A. The mast cell in wound healing. Vet Dermatol 2001; 12 (06) 303-313
    CrossrefPubMedGoogle Scholar
  • 30 Rasmusson I, Ringdén O, Sundberg B, Le Blanc K. Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Exp Cell Res 2005; 305 (01) 33-41
    CrossrefPubMedGoogle Scholar
  • 31 Zhang F-G, Tang X-F. New advances in the mesenchymal stem cells therapy against skin flaps necrosis. World J Stem Cells 2014; 6 (04) 491-496
    CrossrefPubMedGoogle Scholar